Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /530477
chevron_leftBack

Vikram Thermo (India) Ltd.

530477
BSE: 530477 Delayed
165.55INR -2.1%
1.94 USD
As of 24 April 2025, Vikram Thermo (India) Ltd. has a market cap of $64.62M USD, ranking #23216 globally and #1705 in India. It ranks #2331 in the Healthcare sector, and #515 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
23216
Country Rank
1705
Sector Rank
2331
Industry Rank
515
Key Stats
Market Cap
$64.62MUSD
5.51B INR
Enterprise Value
$63.15MUSD
5.4B INR
Revenue (TTM)
$17.77MUSD
1.52B INR
EBITDA (TTM)
$5.3MUSD
452.78M INR
Net Income (TTM)
$1.05MUSD
89.58M INR
EBITDA Margin
30%
Profit Margin
5.9%
PE Ratio
60.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dhirajlal Patel open_in_new
Employees
149
Founded
1985
Website
vikramthermo.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.1% -1.5% -7% -8.4% -5.2% 13%
Upcoming Earnings
Earnings Date
Thu, May 29

Markets

Exchange Ticker Price
Bombay Stock Exchange
MIC: XBOM
PRIMARY
530477 (VIKRAMTH)
Vikram Thermo (India) Ltd
ISIN: INE337E01010
Shares Out.:
31.358M1 Shares Float: 4.181M2
TV:
SA:
YF:
GF:
BA:
MS:
165.55 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Vikram Thermo (India) Ltd.

Vikram Thermo (India) Limited engages in the manufacture, marketing, and export of pharmaceutical excipients and chemicals in India and internationally. The company offers pharmaceutical polymer products, such as DRUGCOAT, a methacrylic co-polymer-based pharma polymer used for enteric and protective coating, taste masking, and sustained release formulation; DRCOAT, a ready to use tablet coating system for enteric and film coating, moisture barrier, and specialty coating applications in the pharmaceutical industry; and diphenyl oxide used as perfumery stabilizer and for manufacturing heat transfer fluids. It also provides cosmetic polymers comprising AQUAPOL polymer, an acrylic emulsion capable of suspending, stabilizing, thickening, and improving the appearance of high surfactant-based cleansing products. In addition, the company offers ion exchange polymers, including APION: An-Ion Exchange Cross Linked Polymers which are excipients that provides formulation flexibility to problems like disintegration and taste masking of bitter API. The company was founded in 1985 and is based in Ahmedabad, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.13B
4.19T INR
76K%
Divi's Laboratories Ltd.
DIVISLAB
$18.39B
1.57T INR
28K%
Cipla Ltd.
CIPLA
$14.46B
1.23T INR
22K%
Torrent Pharmaceuticals Ltd.
TORNTPHARM
$13.23B
1.13T INR
20K%
Mankind Pharma Ltd.
MANKIND
$12.47B
1.06T INR
19K%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
104K%
Merck KGaA
MRK
$59.42B
52.43B EUR
92K%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
72K%
Haleon plc
HLN
$45.57B
34.34B GBP
70K%
Galderma Group AG
GALD
$23.06B
19.13B CHF
36K%